Download PDF
Horm Metab Res 2020; 52(04): 252
DOI: 10.1055/a-1089-7970
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

Response to Letter to the Editor Entitled: Concerning the Article by Arezoo Maleki-Hajiagha et al. Entitled Serum Prostate-Specific Antigen Level in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Arezoo Maleki-Hajiagha
1   Research Development Center, Tehran University of Medical Sciences, Tehran, Iran
,
Maryam Razavi
2   Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
,
Mahroo Rezaeinejad
3   Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran
,
Mahdi Sepidarkish
4   Department of Epidemiology and Reproductive Health, ACECR, Tehran, Iran
,
Ahmad Mehri
5   Department of Epidemiology and Biostatistics, Tehran University of Medical Science, Tehran, Iran
,
Samira Vesali
4   Department of Epidemiology and Reproductive Health, ACECR, Tehran, Iran
,
Zahra Allameh
6   Department of Obstetrics and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran
› Author Affiliations
Further Information

Publication History

Publication Date:
08 April 2020 (online)

Also available at
    Permissions and Reprints

Letter to:

Serum Prostate-Specific Antigen Level in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-analysisHorm Metab Res 2019; 51(04): 230-242
DOI: 10.1055/a-0863-5779

Dear Editor,

We thank Kunicki et al. [1] for their interest in our paper [2] and for taking the time to give relevant and important comments regarding the inclusion of hirsutism or hyperandrogenism cases in our study. We agree with Kunicki et al. that the title is not appropriate, and it was better if the title of the article was: Serum Prostate-Specific Antigen Level in Women with Polycystic Ovary Syndrome and Hyperandrogenism: A Systematic Review and Meta-Analysis. Also, we should make some minor editing in the manuscript text.

 

  • References

  • 1 Kunicki M, Rudnicka E, Smolarczyk R. Concerning the article by Arezoo Maleki-Hajiagha et al. entitled: serum prostate-specific antigen level in women with polycystic ovary syndrome: a systematic review and meta-analysis. Horm Metab Res 2020; 52-251
    PubMedSearch in Google Scholar
  • 2 Maleki-Hajiagha A, Razavi M, Rezaeinejad M. et al. Serum prostate-specific antigen level in women with polycystic ovary syndrome: a systematic review and meta-analysis. Horm Metab Res 2019; 51: 230-242
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Melegos DN, Yu H, Ashok M. et al. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997; 82: 777-780
    CrossrefPubMedSearch in Google Scholar
  • 4 Azziz R, Carmina E, Dewailly D. et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245
    CrossrefPubMedSearch in Google Scholar
  • 5 Johnson T, Kaplan L, Ouyang P. et al. National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome (PCOS). NIH EbMW Report Bethesda, NIH 2012; 1: 1-14
    PubMedSearch in Google Scholar
  • 6 Eshre TR. Group A-SPCW Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
    PubMedSearch in Google Scholar